Biphasic insulin aspart vs Empagliflozin
National NHS prescribing compared (Prescription Cost Analysis)
Empagliflozin was dispensed 7.4× as often as Biphasic insulin aspart in March 2026 — 370,826 items versus 49,836 in England.
49,836items
Biphasic insulin aspart · March 2026
NHSBSA Prescription Cost Analysis
370,826items
Empagliflozin · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Biphasic insulin aspart versus Empagliflozin: national items dispensed by month
▬ Biphasic insulin aspart · ╌ Empagliflozin
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Biphasic insulin aspart | Empagliflozin |
|---|---|---|
| Items, March 2026 | 49,836 | 370,826 |
| Items, last 12 months | 618,619 | 4,715,991 |
| Net ingredient cost, March 2026 | £2,365,581 | £14,469,209 |
See the full profile for Biphasic insulin aspart or Empagliflozin.